Ubs Asset Management Americas Inc Evolus, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 108,231 shares of EOLS stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,231
Previous 116,532
7.12%
Holding current value
$1.08 Million
Previous $1.26 Million
38.69%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EOLS
# of Institutions
168Shares Held
47.8MCall Options Held
130KPut Options Held
51K-
Perceptive Advisors LLC New York, NY5.36MShares$53.6 Million2.27% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$48.5 Million6.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$40.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$32 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$28.2 Million2.72% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $561M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...